Clinical Trials Browser

Completed × INDUSTRY × plitidepsin × Clear all

NCT01102426 2020-11-10

ADMYRE

Phase 3 Completed

255 enrolled 32 charts

Multiple Myeloma

NCT02100657 2020-10-12

Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma

Phase 1 Completed

39 enrolled 30 charts

Multiple Myeloma

NCT00884286 2018-04-25

Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma

Phase 2 Completed

67 enrolled 14 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT00788099 2011-06-07

Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas

Phase 1 Completed

Lymphoma, Neoplasms

NCT00229203 2009-12-24

A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

Phase 2 Completed

51 enrolled 10 charts

Multiple Myeloma, Neoplasms, Plasma Cell